557 related articles for article (PubMed ID: 16751101)
1. PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.
Lin X; Duan X; Liang YY; Su Y; Wrighton KH; Long J; Hu M; Davis CM; Wang J; Brunicardi FC; Shi Y; Chen YG; Meng A; Feng XH
Cell; 2006 Jun; 125(5):915-28. PubMed ID: 16751101
[TBL] [Abstract][Full Text] [Related]
2. A phosphatase controls the fate of receptor-regulated Smads.
Schilling SH; Datto MB; Wang XF
Cell; 2006 Jun; 125(5):838-40. PubMed ID: 16751094
[TBL] [Abstract][Full Text] [Related]
3. PPM1A Functions as a Smad Phosphatase to Terminate TGFβ Signaling.
Lin X; Duan X; Liang YY; Su Y; Wrighton KH; Long J; Hu M; Davis CM; Wang J; Brunicardi FC; Shi Y; Chen YG; Meng A; Feng XH
Cell; 2016 Apr; 165(2):498. PubMed ID: 27058669
[No Abstract] [Full Text] [Related]
4. Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway.
Bu S; Kapanadze B; Hsu T; Trojanowska M
J Biol Chem; 2008 Jul; 283(28):19593-602. PubMed ID: 18482992
[TBL] [Abstract][Full Text] [Related]
5. PPM1A dephosphorylates RanBP3 to enable efficient nuclear export of Smad2 and Smad3.
Dai F; Shen T; Li Z; Lin X; Feng XH
EMBO Rep; 2011 Oct; 12(11):1175-81. PubMed ID: 21960005
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.
Akool el-S; Doller A; Müller R; Gutwein P; Xin C; Huwiler A; Pfeilschifter J; Eberhardt W
J Biol Chem; 2005 Nov; 280(47):39403-16. PubMed ID: 16183640
[TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 5 modulates SMAD3 function in the transforming growth factor-β pathway.
Bruce DL; Macartney T; Yong W; Shou W; Sapkota GP
Cell Signal; 2012 Nov; 24(11):1999-2006. PubMed ID: 22781750
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TGF-β signaling at the nuclear envelope: characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A.
Bourgeois B; Gilquin B; Tellier-Lebègue C; Östlund C; Wu W; Pérez J; El Hage P; Lallemand F; Worman HJ; Zinn-Justin S
Sci Signal; 2013 Jun; 6(280):ra49. PubMed ID: 23779087
[TBL] [Abstract][Full Text] [Related]
9. Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-β/Smad signaling pathway.
Geng J; Fan J; Ouyang Q; Zhang X; Zhang X; Yu J; Xu Z; Li Q; Yao X; Liu X; Zheng J
Oncotarget; 2014 Jul; 5(14):5700-11. PubMed ID: 25026293
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling.
Nyati S; Schinske K; Ray D; Nyati MK; Ross BD; Rehemtulla A
Clin Cancer Res; 2011 Dec; 17(23):7424-39. PubMed ID: 21948232
[TBL] [Abstract][Full Text] [Related]
11. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
Jin Q; Gao G; Mulder KM
J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
[TBL] [Abstract][Full Text] [Related]
12. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway.
Duan X; Liang YY; Feng XH; Lin X
J Biol Chem; 2006 Dec; 281(48):36526-32. PubMed ID: 16931515
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
14. A Smad3 transgenic reporter reveals TGF-beta control of zebrafish spinal cord development.
Casari A; Schiavone M; Facchinello N; Vettori A; Meyer D; Tiso N; Moro E; Argenton F
Dev Biol; 2014 Dec; 396(1):81-93. PubMed ID: 25286120
[TBL] [Abstract][Full Text] [Related]
15. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways.
Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J
J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434
[TBL] [Abstract][Full Text] [Related]
16. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
17. The long-noncoding RNA MALAT1 regulates TGF-β/Smad signaling through formation of a lncRNA-protein complex with Smads, SETD2 and PPM1A in hepatic cells.
Zhang J; Han C; Song K; Chen W; Ungerleider N; Yao L; Ma W; Wu T
PLoS One; 2020; 15(1):e0228160. PubMed ID: 31995604
[TBL] [Abstract][Full Text] [Related]
18. MTMR4 attenuates transforming growth factor beta (TGFbeta) signaling by dephosphorylating R-Smads in endosomes.
Yu J; Pan L; Qin X; Chen H; Xu Y; Chen Y; Tang H
J Biol Chem; 2010 Mar; 285(11):8454-62. PubMed ID: 20061380
[TBL] [Abstract][Full Text] [Related]
19. Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair.
Samarakoon R; Rehfuss A; Khakoo NS; Falke LL; Dobberfuhl AD; Helo S; Overstreet JM; Goldschmeding R; Higgins PJ
FASEB J; 2016 Oct; 30(10):3308-3320. PubMed ID: 27328942
[TBL] [Abstract][Full Text] [Related]
20. Small C-terminal domain phosphatases dephosphorylate the regulatory linker regions of Smad2 and Smad3 to enhance transforming growth factor-beta signaling.
Wrighton KH; Willis D; Long J; Liu F; Lin X; Feng XH
J Biol Chem; 2006 Dec; 281(50):38365-75. PubMed ID: 17035229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
